Global Enteral Feeding Formulas Market Report, 2019: Analysis & Forecast, 2017 to 2026 – ResearchAndMarkets.com
According to this research, the Global Enteral Feeding Formulas market accounted for
Some of the key factors influencing the market growth include rising prevalence of chronic diseases and disorders, growing geriatric population, growing number of preterm births and rising demand for homecare. However, complications associated with enteral feeding are hindering the market growth.
Amongst Product, the standard formulas segment has considerable growth during the forecast period. The growth of this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.
By Geography,
Some of the key players in global enteral feeding formulas market are Abbott Laboratories, Novartis AG,
What the report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Enteral Feeding Formulas Market, By Product
5.1 Introduction
5.2 Disease-Specific Formulas
5.2.1 Hepatic Formulas
5.2.2 Renal Formulas
5.2.3 Pulmonary Formulas
5.2.4 Liver Formulas
5.2.5 Immuno Modulatory Formulas
5.2.6 Gastrointestinal Dysfunction Formulas
5.2.7 Diabetic Formulas
5.2.8 Other Formulas
5.3 Standard Formulas
5.3.1 Monomeric Formulas
5.3.2 Polymeric Formulas
5.3.3 Calorie Dense Products
5.3.3.1 1.0 Calorie/ML
5.3.3.2 1.2 Calorie/ML
5.3.3.3 1.5 Calorie/ML
5.3.3.4 2.0 Calorie/ML
5.4 Blenderized Formula
5.4.1 Vegetables
5.4.2 Rice
5.4.3 Fruits
5.4.3.1 Avocado
5.4.3.2 Bananas
5.4.3.3 Raspberries
5.4.3.4 Sweet Potatoes
5.4.3.5 Strawberries
5.4.3.6 Quinoa
5.4.3.7 Blueberries
5.4.3.8 Other Fruits
5.4.4 Flax seed
5.4.5 Meat
5.4.6 Other Blenderized Formulas
5.5 Fiber Supplemented Formula
5.6 Semi-Elemental Formula
5.7 Polymeric Formula
5.8 Elemental Formula
5.9 Hydrolyzed Formula
5.10 Other Products
6 Global Enteral Feeding Formulas Market, By Stage
6.1 Introduction
6.2 Pediatrics
6.2.1 Oral Supplements
6.2.2 Tube Feeding Formulas
6.2.3 Infant Formulas
6.3 Adults
6.3.1 Modulars
6.3.2 Oral Supplements
6.3.3 Tube Feeding Formulas
7 Global Enteral Feeding Formulas Market, By Form
7.1 Introduction
7.2 Liquid
7.3 Powder
7.4 Other Forms
8 Global Enteral Feeding Formulas Market, By Mode of Delivery
8.1 Introduction
8.2 Oral
8.3 Trans-pyloric
8.3.1 Gastro-Jejunostomy
8.3.2 Naso-Jejunal
8.3.3 Jejunostomy
8.4 Gastric
8.4.1 Gastrostomy
8.4.2 Nasogastric
9 Global Enteral Feeding Formulas Market, By Flavor Type
9.1 Introduction
9.2 Flavored
9.2.1 Vanilla
9.2.2 Butter Pecan
9.2.3 Strawberry
9.2.4 Other Flavors
9.3 Unflavored
10 Global Enteral Feeding Formulas Market, By Therapeutic Area
10.1 Introduction
10.2 Malabsorption
10.3 Crohn's disease
10.4 Cystic Fibrosis
10.5 Congenital Heart Disease
10.6 Kidney Failure
10.7 Choanal atresia
10.8 Inflammatory bowel disease
10.9 Short Bowel Syndrome
10.10 Other Therapeutic Areas
11 Global Enteral Feeding Formulas Market, By Application
11.1 Introduction
11.2 Gastroenterology
11.3 Diabetes
11.4 Neurology
11.5 Oncology
11.6 Critical Care
11.7 Other Applications
12 Global Enteral Feeding Formulas Market, By End User
12.1 Introduction
12.2 Long-Term Care Facilities
12.2.1 Assisted Living Facilities
12.2.2
12.2.3 Home Care Agencies and Hospices
12.3 Hospitals
13 Global Enteral Feeding Formulas Market, By Geography
13.1 Introduction
13.2
13.2.1 US
13.2.2
13.2.3
13.3
13.3.1
13.3.2
13.3.3
13.3.4
13.3.5
13.3.6 Rest of
13.4
13.4.1
13.4.2
13.4.3
13.4.4
13.4.5
13.4.6
13.4.7 Rest of
13.5
13.5.1
13.5.2
13.5.3
13.5.4 Rest of
13.6
13.6.1
13.6.2
13.6.3
13.6.4
13.6.5 Rest of
14 Key Developments
14.1 Agreements, Partnerships,
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.4 Expansions
14.5 Other Key Strategies
15 Company Profiling
15.1 Abbott Laboratories
15.2 Novartis AG
15.3
15.4 Nestle S.A.
15.5 Trovita Health Science
15.6 Danone Nutricia
15.7 Fresenius Kabi
15.8 Hormel Foods Corporation
15.9 Meiji Holdings Co. Ltd.
15.10
15.11
15.12
15.13 Merck & Co. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ije76y
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005708/en/
ResearchAndMarkets.com
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices
Source:
Drug cost bill advances but GOP resistance spells trouble
Booker takes on Biden in bid to break through crowded field
Advisor News
- How advisors can prepare clients for an uncertain retirement landscape
- Investors aren’t waiting out uncertainty
- Transamerica and Advo(k)ate Advisors launch pooled employer plan
- ‘I wish I’d met him sooner:’ Karlan Tucker remembered for integrity, faith
- Why women must be more engaged in investing
More Advisor NewsAnnuity News
- AM Best Revises Outlooks to Negative for Subsidiaries of Group 1001 Insurance Holdings, LLC
- Market-value adjusted annuities: Key considerations for advisors
- Private equity’s next play in insurance
- Immediate Care Plan: A new solution for funding LTC
- Delaware Life Launches a New Bonus Fixed Index Annuity Built for Growth, Protection, and Flexibility
More Annuity NewsHealth/Employee Benefits News
- Data on Managed Care Reported by Researchers at University of California Berkeley (Welfare Program Participation Among Us Farmworkers Evidence From Three National Surveys): Managed Care
- ON MEDICAID'S 61ST ANNIVERSARY, A REMINDER PENNSYLVANIA REPUBLICANS CONTINUE TO PUSH DEVASTATING HEALTHCARE CUTS
- ON 61ST ANNIVERSARY OF MEDICAID, 10,000 FEWER ALASKANS HAVE COVERAGE AFTER PASSAGE OF DAN SULLIVAN'S AGENDA
- REMINDER: SUNUNU AND BROWN SUPPORT TRUMP'S BIG UGLY BILL THAT CUT BILLIONS IN HEALTH CARE FUNDING FOR NEW HAMPSHIRE
- UHealth, United have a deal. What Medicare Advantage, other patients should know
More Health/Employee Benefits NewsLife Insurance News
- AM Best Revises Outlooks to Negative for Subsidiaries of Group 1001 Insurance Holdings, LLC
- Court sides with Ameritas in denying $4M STOLI payout to Wells Fargo
- AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of The Fortegra Group, Inc.’s Insurance Subsidiaries
- Yancey Jr., Delos Harley
- Vincent Esparza CFP, CLU joins Wilde Wealth Management Group as Senior Wealth Advisor
More Life Insurance News